decades of cosmetic and wound-healing literature No multi-center RCT BPC-157: Limited, Emerging Clinical Evidence 100+ preclinical repair studies Human evidence is thin but real PL-14736 (its clinical-development name) reached abstract-level Phase 1/2 in ulcerative colitis A modern hamstring tendon Phase 2 RCT is recruiting, and an intra-articular knee case series exists Clean early-phase safety
Highly recommend, now my number one choice, I will also be exploring other VITAstir options Love it
This matters because poorly organized scar tissue often leads to re-injury
Are there any side effects
Label the vial with the date, concentration (2500mcg/ml), and expiration date (28 days from reconstitution)
Potential interaction considerations Despite largely complementary mechanisms, some pathway overlap exists between BPC-157 and TB-500